Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients.
Identifieur interne : 005460 ( Main/Exploration ); précédent : 005459; suivant : 005461Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients.
Auteurs : Yulin Shi [République populaire de Chine] ; Zhuoyue Wan ; Linhai Li ; Ping Li ; Chufang Li ; Qingjun Ma ; Cheng CaoSource :
- Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [ 1386-6532 ] ; 2004.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Anticorps antiviraux (sang), Facteurs temps, Humains, Immunoglobuline G (sang), Immunoglobuline M (sang), Nucléocapside (immunologie), Sujet âgé, Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (virologie), Technique d'immunofluorescence indirecte, Test ELISA, Tests de neutralisation, Virus du SRAS (immunologie).
- MESH :
- immunologie : Nucléocapside, Syndrome respiratoire aigu sévère, Virus du SRAS.
- sang : Anticorps antiviraux, Immunoglobuline G, Immunoglobuline M.
- virologie : Syndrome respiratoire aigu sévère.
- Adulte, Adulte d'âge moyen, Facteurs temps, Humains, Sujet âgé, Technique d'immunofluorescence indirecte, Test ELISA, Tests de neutralisation.
English descriptors
- KwdEn :
- Adult, Aged, Antibodies, Viral (blood), Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, Indirect, Humans, Immunoglobulin G (blood), Immunoglobulin M (blood), Middle Aged, Neutralization Tests, Nucleocapsid (immunology), SARS Virus (immunology), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (virology), Time Factors.
- MESH :
- chemical , blood : Antibodies, Viral, Immunoglobulin G, Immunoglobulin M.
- immunology : Nucleocapsid, SARS Virus, Severe Acute Respiratory Syndrome.
- virology : Severe Acute Respiratory Syndrome.
- Adult, Aged, Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, Indirect, Humans, Middle Aged, Neutralization Tests, Time Factors.
Abstract
SARS-Cov is the etiologic agent of severe acute respiratory syndrome. An understanding of the antibody responses to the viral components is very important for diagnosis and vaccine development.
DOI: 10.1016/j.jcv.2004.05.006
PubMed: 15288616
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002C40
- to stream PubMed, to step Curation: 002C40
- to stream PubMed, to step Checkpoint: 002E24
- to stream Ncbi, to step Merge: 000974
- to stream Ncbi, to step Curation: 000974
- to stream Ncbi, to step Checkpoint: 000974
- to stream Main, to step Merge: 005901
- to stream Main, to step Curation: 005460
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients.</title><author><name sortKey="Shi, Yulin" sort="Shi, Yulin" uniqKey="Shi Y" first="Yulin" last="Shi">Yulin Shi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Laboratory, General Hospital of Guangzhou, Military Command, 510010, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Laboratory, General Hospital of Guangzhou, Military Command, 510010</wicri:regionArea><wicri:noRegion>510010</wicri:noRegion></affiliation></author><author><name sortKey="Wan, Zhuoyue" sort="Wan, Zhuoyue" uniqKey="Wan Z" first="Zhuoyue" last="Wan">Zhuoyue Wan</name></author><author><name sortKey="Li, Linhai" sort="Li, Linhai" uniqKey="Li L" first="Linhai" last="Li">Linhai Li</name></author><author><name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name></author><author><name sortKey="Li, Chufang" sort="Li, Chufang" uniqKey="Li C" first="Chufang" last="Li">Chufang Li</name></author><author><name sortKey="Ma, Qingjun" sort="Ma, Qingjun" uniqKey="Ma Q" first="Qingjun" last="Ma">Qingjun Ma</name></author><author><name sortKey="Cao, Cheng" sort="Cao, Cheng" uniqKey="Cao C" first="Cheng" last="Cao">Cheng Cao</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15288616</idno><idno type="pmid">15288616</idno><idno type="doi">10.1016/j.jcv.2004.05.006</idno><idno type="wicri:Area/PubMed/Corpus">002C40</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C40</idno><idno type="wicri:Area/PubMed/Curation">002C40</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C40</idno><idno type="wicri:Area/PubMed/Checkpoint">002E24</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002E24</idno><idno type="wicri:Area/Ncbi/Merge">000974</idno><idno type="wicri:Area/Ncbi/Curation">000974</idno><idno type="wicri:Area/Ncbi/Checkpoint">000974</idno><idno type="wicri:doubleKey">1386-6532:2004:Shi Y:antibody:responses:against</idno><idno type="wicri:Area/Main/Merge">005901</idno><idno type="wicri:Area/Main/Curation">005460</idno><idno type="wicri:Area/Main/Exploration">005460</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients.</title><author><name sortKey="Shi, Yulin" sort="Shi, Yulin" uniqKey="Shi Y" first="Yulin" last="Shi">Yulin Shi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Laboratory, General Hospital of Guangzhou, Military Command, 510010, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Laboratory, General Hospital of Guangzhou, Military Command, 510010</wicri:regionArea><wicri:noRegion>510010</wicri:noRegion></affiliation></author><author><name sortKey="Wan, Zhuoyue" sort="Wan, Zhuoyue" uniqKey="Wan Z" first="Zhuoyue" last="Wan">Zhuoyue Wan</name></author><author><name sortKey="Li, Linhai" sort="Li, Linhai" uniqKey="Li L" first="Linhai" last="Li">Linhai Li</name></author><author><name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name></author><author><name sortKey="Li, Chufang" sort="Li, Chufang" uniqKey="Li C" first="Chufang" last="Li">Chufang Li</name></author><author><name sortKey="Ma, Qingjun" sort="Ma, Qingjun" uniqKey="Ma Q" first="Qingjun" last="Ma">Qingjun Ma</name></author><author><name sortKey="Cao, Cheng" sort="Cao, Cheng" uniqKey="Cao C" first="Cheng" last="Cao">Cheng Cao</name></author></analytic><series><title level="j">Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</title><idno type="ISSN">1386-6532</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antibodies, Viral (blood)</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Fluorescent Antibody Technique, Indirect</term><term>Humans</term><term>Immunoglobulin G (blood)</term><term>Immunoglobulin M (blood)</term><term>Middle Aged</term><term>Neutralization Tests</term><term>Nucleocapsid (immunology)</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (immunology)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Time Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps antiviraux (sang)</term><term>Facteurs temps</term><term>Humains</term><term>Immunoglobuline G (sang)</term><term>Immunoglobuline M (sang)</term><term>Nucléocapside (immunologie)</term><term>Sujet âgé</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Technique d'immunofluorescence indirecte</term><term>Test ELISA</term><term>Tests de neutralisation</term><term>Virus du SRAS (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term><term>Immunoglobulin G</term><term>Immunoglobulin M</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Nucléocapside</term><term>Syndrome respiratoire aigu sévère</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Nucleocapsid</term><term>SARS Virus</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term><term>Immunoglobuline G</term><term>Immunoglobuline M</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Fluorescent Antibody Technique, Indirect</term><term>Humans</term><term>Middle Aged</term><term>Neutralization Tests</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs temps</term><term>Humains</term><term>Sujet âgé</term><term>Technique d'immunofluorescence indirecte</term><term>Test ELISA</term><term>Tests de neutralisation</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">SARS-Cov is the etiologic agent of severe acute respiratory syndrome. An understanding of the antibody responses to the viral components is very important for diagnosis and vaccine development.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><noCountry><name sortKey="Cao, Cheng" sort="Cao, Cheng" uniqKey="Cao C" first="Cheng" last="Cao">Cheng Cao</name><name sortKey="Li, Chufang" sort="Li, Chufang" uniqKey="Li C" first="Chufang" last="Li">Chufang Li</name><name sortKey="Li, Linhai" sort="Li, Linhai" uniqKey="Li L" first="Linhai" last="Li">Linhai Li</name><name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name><name sortKey="Ma, Qingjun" sort="Ma, Qingjun" uniqKey="Ma Q" first="Qingjun" last="Ma">Qingjun Ma</name><name sortKey="Wan, Zhuoyue" sort="Wan, Zhuoyue" uniqKey="Wan Z" first="Zhuoyue" last="Wan">Zhuoyue Wan</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="Shi, Yulin" sort="Shi, Yulin" uniqKey="Shi Y" first="Yulin" last="Shi">Yulin Shi</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005460 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005460 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:15288616
|texte= Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15288616" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |